Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO01270) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Dehydroascorbic acid
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 2 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=440667"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Induced by This Xenobiotics | ||||||
| Catalase (CAT) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Dehydroascorbic acid as pre-conditioner: protection from lipopolysaccharide induced mitochondrial damage. Free Radic Res. 2010 Mar;44(3):283-92. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.